ZA200700758B - Polysulfated glycosides and salts thereof - Google Patents

Polysulfated glycosides and salts thereof

Info

Publication number
ZA200700758B
ZA200700758B ZA200700758A ZA200700758A ZA200700758B ZA 200700758 B ZA200700758 B ZA 200700758B ZA 200700758 A ZA200700758 A ZA 200700758A ZA 200700758 A ZA200700758 A ZA 200700758A ZA 200700758 B ZA200700758 B ZA 200700758B
Authority
ZA
South Africa
Prior art keywords
salts
polysulfated glycosides
polysulfated
glycosides
asthma
Prior art date
Application number
ZA200700758A
Other languages
English (en)
Inventor
Kuszmann Janos
Kurucz Istva
Medgyes Gabor
Bodor Nicholas
Original Assignee
Ivax Drug Res Inst Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ivax Drug Res Inst Ltd filed Critical Ivax Drug Res Inst Ltd
Publication of ZA200700758B publication Critical patent/ZA200700758B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
ZA200700758A 2004-08-05 2005-08-05 Polysulfated glycosides and salts thereof ZA200700758B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US59914804P 2004-08-05 2004-08-05

Publications (1)

Publication Number Publication Date
ZA200700758B true ZA200700758B (en) 2008-08-27

Family

ID=35781354

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200700758A ZA200700758B (en) 2004-08-05 2005-08-05 Polysulfated glycosides and salts thereof

Country Status (25)

Country Link
US (2) US7902158B2 (ru)
EP (1) EP1778709B1 (ru)
JP (1) JP5164572B2 (ru)
KR (1) KR101097702B1 (ru)
CN (1) CN101014607B (ru)
AT (1) ATE397006T1 (ru)
AU (1) AU2005271349B2 (ru)
BR (1) BRPI0513095A (ru)
CA (1) CA2576131C (ru)
CY (1) CY1108900T1 (ru)
DE (1) DE602005007244D1 (ru)
DK (1) DK1778709T3 (ru)
ES (1) ES2308536T3 (ru)
HK (1) HK1098758A1 (ru)
IL (1) IL181095A (ru)
MX (1) MX2007001444A (ru)
NO (1) NO20070987L (ru)
NZ (1) NZ553292A (ru)
PL (1) PL1778709T3 (ru)
PT (1) PT1778709E (ru)
RU (1) RU2413734C2 (ru)
SI (1) SI1778709T1 (ru)
UA (1) UA87154C2 (ru)
WO (1) WO2006017726A2 (ru)
ZA (1) ZA200700758B (ru)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE397006T1 (de) 2004-08-05 2008-06-15 Ivax Drug Res Inst Ltd Polysulfatierte glykoside und salze davon
WO2010037180A1 (en) * 2008-10-03 2010-04-08 Glycan Biosciences Pty Ltd Anionic oligosaccharide conjugates
US8993536B2 (en) * 2009-02-02 2015-03-31 Otsuka Chemical Co., Ltd. Low-molecular polysulfated hyaluronic acid derivative and medicine containing same
NZ598922A (en) * 2009-08-31 2014-03-28 Depomed Inc Gastric retentive pharmaceutical compositions for immediate and extended release of acetaminophen
CN102711463B (zh) 2009-12-03 2015-05-13 Opko健康公司 超硫酸化双糖制剂
EP2632259A4 (en) * 2010-10-29 2015-04-29 Opko Health Inc HYPERSULATED DISACCHARIDES FOR THE TREATMENT OF ELASTASE-MEDIATED DISEASES
WO2012058719A1 (en) * 2010-11-02 2012-05-10 The Universtity Of Sydney Inhalable compositions
LT3274347T (lt) 2015-03-26 2020-12-10 Giuliani S.P.A. Junginiai, turintys antioksidacinį aktyvumą prieš laisvuosius radikalus ir priešuždegiminį aktyvumą, ir atitinkamos farmacinės kompozicijos, skirtos odos priežiūrai
TW201815394A (zh) 2016-08-16 2018-05-01 美商歐科製藥有限公司 具有改良口服生物可利用性之純七硫酸化雙醣
JP6225321B1 (ja) 2016-08-31 2017-11-08 王子ホールディングス株式会社 ポリ硫酸ペントサンの製造方法
KR102559743B1 (ko) 2016-08-31 2023-07-25 오지 홀딩스 가부시키가이샤 산성 자일로올리고당의 제조 방법 및 산성 자일로올리고당
JP6281659B1 (ja) * 2017-02-28 2018-02-21 王子ホールディングス株式会社 ポリ硫酸ペントサン、医薬組成物及び抗凝固剤
CA3065747A1 (en) 2017-05-31 2018-12-06 Oji Holdings Corporation Moisturizing composition comprising pentosan polysulfate
MX2020002726A (es) 2017-09-12 2020-07-20 Oji Holdings Corp Polisulfato de pentosan y metodo para producir polisulfato de pentosan.
AU2018387999B2 (en) 2017-12-20 2021-06-17 Oji Holdings Corporation Pentosan polysulfate and medicine containing pentosan polysulfate

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4021544A (en) * 1976-07-12 1977-05-03 American Cyanamid Company Complement inhibitors
DE3734815A1 (de) * 1987-10-14 1989-04-27 Luitpold Werk Chem Pharm Polyschwefelsaeureester von bis-aldonsaeureamiden und deren derivaten, verfahren zu ihrer herstellung und arzneimittel
DK505488D0 (da) * 1987-12-21 1988-09-09 Bar Shalom Daniel Middel og anvendelse af samme
US5380716A (en) * 1988-12-15 1995-01-10 Glycomed, Inc. Sulfated polysaccharides as inhibitors of smooth muscle cell proliferation
IL102758A (en) 1991-08-23 1997-03-18 Akzo Nv Glycosaminoglycanoid derivatives, their preparation and pharmaceutical compositions comprising them
JPH05164572A (ja) 1991-12-12 1993-06-29 Y E Data Inc エンコーダ
EP0649427B1 (en) 1992-06-01 1998-01-28 The Biomembrane Institute Sequential removal of monosaccharides from the reducing end of oligosaccharides and uses thereof
DE4408248A1 (de) * 1994-03-11 1995-09-14 Hoechst Ag Physiologisch verträgliche und physiologisch abbaubare Kohlenhydrat-Mimetika, ein Verfahren zur Herstellung und ihre Verwendung
US5783568A (en) * 1994-06-10 1998-07-21 Sugen, Inc. Methods for treating cancer and other cell proliferative diseases
JPH08109134A (ja) * 1994-10-11 1996-04-30 Sanwa Kagaku Kenkyusho Co Ltd 細胞変成抑制並びに臓器毒性軽減剤
US6153736A (en) * 1995-09-27 2000-11-28 The Liposome Company, Inc. Modified ether glyceroglycolipids
JPH09183789A (ja) 1995-10-31 1997-07-15 Sanwa Kagaku Kenkyusho Co Ltd 新規な硫酸化及び燐酸化糖誘導体、その製法及び用途
AU5706699A (en) * 1998-11-24 2000-06-13 American Home Products Corporation Benzyllactobionamides as inhibitors of smooth muscle cell proliferation
JP4913272B2 (ja) 1999-01-07 2012-04-11 生化学工業株式会社 オリゴ糖の製造方法ならびに新規オリゴ糖およびそれを含む医薬組成物
JP2005510453A (ja) * 2001-04-16 2005-04-21 イヴァックス リサーチ インコーポレイテッド 高硫酸化二糖類及び炎症治療のためのそれらの使用方法
CN1668755A (zh) * 2002-06-07 2005-09-14 甜糖（曼海姆/奥克森富特）股份公司 半乳糖苷基异麦芽酮糖醇、其生产方法及应用
ATE397006T1 (de) 2004-08-05 2008-06-15 Ivax Drug Res Inst Ltd Polysulfatierte glykoside und salze davon
WO2010044733A1 (en) 2008-10-16 2010-04-22 Rolls-Royce Aktiebolag Method and arrangement for propeller pitch control

Also Published As

Publication number Publication date
DK1778709T3 (da) 2008-09-22
CA2576131C (en) 2012-04-24
AU2005271349A1 (en) 2006-02-16
DE602005007244D1 (de) 2008-07-10
US7902158B2 (en) 2011-03-08
IL181095A (en) 2013-07-31
RU2413734C2 (ru) 2011-03-10
RU2007107935A (ru) 2008-09-10
NZ553292A (en) 2009-06-26
MX2007001444A (es) 2007-07-04
JP5164572B2 (ja) 2013-03-21
WO2006017726A3 (en) 2006-04-20
UA87154C2 (ru) 2009-06-25
WO2006017726A2 (en) 2006-02-16
CA2576131A1 (en) 2006-02-16
ATE397006T1 (de) 2008-06-15
PT1778709E (pt) 2008-07-24
KR20070042188A (ko) 2007-04-20
CY1108900T1 (el) 2014-07-02
US8987216B2 (en) 2015-03-24
HK1098758A1 (en) 2007-07-27
CN101014607B (zh) 2014-05-14
AU2005271349B2 (en) 2011-10-27
CN101014607A (zh) 2007-08-08
JP2008509156A (ja) 2008-03-27
IL181095A0 (en) 2007-07-04
US20110118198A1 (en) 2011-05-19
KR101097702B1 (ko) 2011-12-22
BRPI0513095A (pt) 2008-03-11
NO20070987L (no) 2007-04-11
PL1778709T3 (pl) 2008-10-31
EP1778709B1 (en) 2008-05-28
SI1778709T1 (sl) 2008-12-31
EP1778709A2 (en) 2007-05-02
US20070281893A1 (en) 2007-12-06
ES2308536T3 (es) 2008-12-01

Similar Documents

Publication Publication Date Title
HK1098758A1 (en) Polysulfated glycosides and salts thereof
HK1057899A1 (en) Arylmethylamine derivatives for use as tryptase inhibitors
MX2012000488A (es) Terapia de combinacion para el tratamiento de la diabetes.
IL187005A0 (en) Diacylglycerol acyltransferase inhibitors
GB0625648D0 (en) Compounds
HK1087702A1 (en) Arylmethylamine derivatives for use as tryptase inhibitors
WO2008042688A3 (en) Phlorizin analogs as inhibitors of sodium glucose co-transporter 2
HK1142062A1 (en) Oxadiazole derivatives active on sphingosine-1-phosphate (s1p)
WO2007143607A3 (en) Method of treating atrophic vaginitis
MY139577A (en) Anti-inflammatory androstane derivative
WO2006017752A3 (en) Sulfated oligosaccharides
WO2007136741A3 (en) N-desmethyl-doxepin and methods of using the same to treat sleep disorders
KR102647942B1 (ko) 섬유증 치료제
WO2005112914A3 (en) Phenolic antioxidants for the treatment of disorders including arthritis, asthma and coronary artery disease
JP2007501270A5 (ru)
WO2005023792A3 (en) Macrocyclic compounds useful as pharmaceuticals
WO2006017727A3 (en) Glycosides and salts thereof
IS7899A (is) Samverkandi samsetning sem felur í sér róflúmílast og (R.R)-formóteról
WO2005105766A3 (en) Arylphenylamino-and arylphenylether-sulfide derivatives, useful for the treatment of inflammatory and immune diseases, and pharmaceutical compositions containing them
MXPA05008236A (es) Derivados novedosos de 2,3-benzodiazepina substituidos.
WO2004069195A3 (en) Methods and compositions for treating inflammatory disorders of the airways
WO2008022242A3 (en) Synthesis of propyl phenoxy ethers and use as delivery agents
SG126014A1 (en) Treatment of asthma
NZ622993A (en) Combination therapy for the treatment of diabetes
UA86813C2 (ru) Ингибиторы бета-гидроксистероидной дегидрогеназы типа 1